Buyani Ndlovu | Molecular and Cell Biology | Best Researcher Award

Published on by Cognitive Scientist Awards

Mr. Buyani Ndlovu | Molecular and Cell Biology | Best Researcher Award

Buyani Ndlovu is a South African research scientist specializing in molecular biology, biotechnology, and microbiology. With a Ph.D. from the University of Cape Town, his groundbreaking doctoral work focused on developing plant-produced mRNA vaccines and novel expression vectors against avian viral diseases. Over the past decade, Buyani has honed a robust repertoire of molecular techniques and contributed significantly to academic research, teaching, and mentorship. He has held roles ranging from Research Scientist at Roche DIA to academic tutor and seminar organiser at UCT. His passion for scientific innovation is matched by his commitment to student development and community leadership. Through multiple scholarships and peer-reviewed publications, Buyani has demonstrated his academic excellence and research prowess. His work has been presented at numerous national and international conferences, highlighting his impact in both academia and applied science. A dedicated professional, he continues to push boundaries in vaccine research and recombinant protein expression technologies.

Profile

🎓 Education

Buyani Ndlovu holds a Ph.D. in Molecular & Cell Biology from the University of Cape Town, where he developed novel plant expression vectors and a plant-produced mRNA vaccine candidate against beak and feather disease virus. His MSc in Wine Biotechnology from Stellenbosch University focused on the identification and characterization of bacteriocins produced by wine-isolated LAB strains. He also completed a BSc Honours in Cell Biology and a BSc in Biological Sciences at the University of KwaZulu-Natal, where his undergraduate research investigated seed desiccation sensitivity and shell deformities in abalone. He has consistently secured competitive scholarships throughout his academic journey, including the CSIR-IBS, PRF, and NRF Doctoral Innovation Scholarships. Buyani’s academic background reflects a consistent trajectory of scientific curiosity, methodical investigation, and a multidisciplinary approach to molecular sciences. His academic excellence is further supported by his attendance at international workshops, such as the Oomycete Bioinformatic Training Workshop at Virginia Tech, enhancing his global research perspective.

🧪 Experience

Buyani Ndlovu currently serves as Scientist II at Roche DIA’s Reagent Research and Design department in Cape Town, contributing to enzyme engineering within the MethylSeq 2025 Project. From 2019 to 2024, he worked at the University of Cape Town as a tutor and laboratory demonstrator in molecular and cell biology, guiding students across various academic levels. His professional journey also includes chairing postgraduate seminars and extensive leadership in residence management at multiple universities. His doctoral research involved cloning, sequencing, and gene expression analysis for vaccine development. He has previously worked with Genestwister Africa as a molecular biology intern and served as a laboratory demonstrator at UKZN. His roles have combined scientific innovation with administrative coordination, mentorship, and public speaking. Notably, he also engaged in field research at Kruger National Park and has consistently been involved in organisational roles within academic residences, showcasing strong leadership and interpersonal skills across his career.

🏅 Awards and Honors

Buyani Ndlovu is the recipient of numerous prestigious academic awards and research scholarships. These include the CSIR-IBS Doctoral Scholarship (ZAR 140,000/year), PRF Doctoral Scholarship (ZAR 55,000/year), and UCT Doctoral Scholarship (ZAR 20,000/year) from 2019 to 2022. He was also awarded the NRF Doctoral Innovation Scholarship (ZAR 110,000/year) in 2015–2016. His early academic promise was recognized through the Technology Innovation Agency Scholarship (ZAR 70,000/year) in 2011–2012 and the Cape Biotech Scholarship (ZAR 50,000) in 2010. He received the USDA Travel Award Fellowship and the WhiteSci Travel Award Scheme to present his research internationally. In addition to financial accolades, his leadership has been recognized through elected roles in academic and student governance. His continuous recognition by multiple institutions underlines both his scholarly achievements and potential for continued excellence in bioscience innovation. These honors have significantly supported his academic trajectory and helped position him as a leader in molecular research.

🔬 Research Focus

Buyani Ndlovu’s research focus lies at the intersection of molecular biology, biotechnology, and microbiology, particularly in the development of plant-based vaccines and novel gene expression systems. His doctoral research introduced innovative replicating plant virus vectors and a plant-derived mRNA vaccine candidate to combat beak and feather disease virus in parrots. He is experienced in DNA/RNA manipulation, recombinant protein expression in plants, bacteria, and mammalian cells, and molecular assay techniques including PCR, ELISA, and Western blotting. His research has broader implications for low-cost vaccine development and sustainable pharmaceutical manufacturing using plant systems. Buyani has also contributed to plant-pathogen interaction studies, notably with Phytophthora cinnamomi, and is interested in functional genomics and synthetic biology. Currently, his work at Roche DIA involves enzyme engineering for diagnostic technologies. With his foundation in grant writing and research communication, he is well-placed to lead interdisciplinary projects that fuse molecular innovation with public health solutions.

✅ Conclusion

Buyani Ndlovu is a highly skilled research scientist with a rich background in molecular biology and biotechnology, marked by academic excellence, impactful research, and leadership. His contributions to plant-based vaccine development and molecular diagnostics highlight his scientific rigor and innovation. Combining technical proficiency with organizational and mentorship skills, he remains dedicated to advancing health sciences through cutting-edge research and collaborative engagement. With a vision to bridge academic knowledge and societal needs, Buyani aspires to transform lives through science. He stands out as a dynamic professional committed to excellence in research, teaching, and scientific leadership.

Publications

  • Immunogenicity of DNA, mRNA and Subunit Vaccines Against Beak and Feather Disease Virus

    2025-07-17 | Journal article
    CONTRIBUTORS: Buyani Ndlovu; Albertha R. van Zyl; Dirk Verwoerd; Edward P. Rybicki; Inga I. Hitzerot

  • Generation of composite Persea americana (Mill.) (avocado) plants: A proof-of-concept-study

    PLOS ONE
    2017-10-20 | Journal article
    DOI: 10.1371/journal.pone.0185896
    Part ofISSN: 1932-6203
    CONTRIBUTORS: S. Ashok Prabhu; Buyani Ndlovu; Juanita Engelbrecht; Noelani van den Berg

  • Screening, identification and characterization of bacteriocins produced by wine-isolated LAB strains

    Journal of Applied Microbiology
    2015-04 | Journal article
    DOI: 10.1111/jam.12752
    Part of ISSN: 1364-5072
    CONTRIBUTORS: B. Ndlovu; H. Schoeman; C.M.A.P. Franz; M. du Toit

Milana Frenkel-Morgenstern | Liquid Biopsy | Women Researcher Award

Published on by Cognitive Scientist Awards

Dr. Milana Frenkel-Morgenstern | Liquid Biopsy | Women Researcher Award

Dr. Milana Frenkel-Morgenstern is an Israeli scientist and Principal Investigator at the Scojen Institute of Synthetic Biology, Reichman University. She specializes in bioinformatics, systems biology, and synthetic biology. With a rich background spanning molecular genetics, computer science, and structural biology, she has held key positions in institutions such as Bar-Ilan University, Weizmann Institute of Science, and the Spanish National Research Centre. She is renowned for her pioneering work in liquid biopsies, chimeric RNAs, and non-invasive diagnostic tools. Dr. Frenkel-Morgenstern has published extensively, served on prestigious evaluation panels, and received numerous fellowships and awards, including the Miguel Servet Fellowship and the Rector Prize for Scientific Innovation. Her leadership in both academic and public scientific communities, combined with a strong record of mentorship and university service, highlights her influential presence in biomedical research. She is also the founder of the “Art in Science” session at ISMB, reflecting her commitment to interdisciplinary innovation.

Profile

🎓 Education

Dr. Frenkel-Morgenstern earned her PhD in Molecular Genetics at the Weizmann Institute of Science under Prof. Shmuel Pietrokovski, specializing in bioinformatics and systems biology. Prior to that, she completed her MSc in Mathematics and Computer Science with a thesis in molecular biology from Bar-Ilan University, mentored by Prof. Ron Unger and Prof. Amihood Amir. Her undergraduate studies were also at Bar-Ilan University, where she earned a BSc in Mathematics and Computer Science. Her multidisciplinary education seamlessly blends life sciences, computational modeling, and mathematical analysis, forming the foundation for her later innovations in biomedical research. This strong computational background, coupled with a deep understanding of molecular biology, positioned her to excel in complex systems analysis, machine learning, and genomics, leading to a distinguished academic and research career. Her training has enabled her to lead translational biomedical projects, particularly in the fields of cancer research, structural bioinformatics, and synthetic biology.

🧪 Experience

Dr. Milana Frenkel-Morgenstern has over two decades of academic and research experience. She is currently Principal Investigator and Senior Lecturer at Reichman University. Prior to this, she was a senior faculty member at Bar-Ilan University’s Azrieli Faculty of Medicine for a decade. Internationally, she served as a staff scientist at the Spanish National Cancer Research Centre (CNIO) and was a postdoctoral fellow in the labs of Prof. Alfonso Valencia and Prof. Uri Alon. She has also been a scientific advisor and educator at the Weizmann Institute’s Davidson Institute. Dr. Frenkel-Morgenstern has taught a range of graduate-level courses in genomics, bioinformatics, and computational biology. She has been deeply involved in institutional governance, serving on data science boards, senate committees, and multiple departmental leadership roles. Her professional journey reflects a blend of research excellence, teaching dedication, and scientific outreach, including organizing the “Art in Science” initiative for ISMB/ECCB.

🏅 Awards and Honors

Dr. Frenkel-Morgenstern has received numerous prestigious awards recognizing her research and innovation. She was awarded the Rector Prize for Scientific Innovation by Bar-Ilan University in 2021, and the Bioinfo4Women Fellowship by the Barcelona Supercomputing Center from 2016–2019. Her work on RNA sequencing earned her the Miguel Servet Fellowship (2011–2015), and she received international postdoctoral fellowships from Caja Navarra Foundation and Horvitz Foundation. Her academic contributions have been recognized through several Travel Awards from ISMB, ECCB, and RECOMB, and she earned Outstanding Poster Awards in international conferences. As a guest editor for leading journals and evaluator for major funding bodies (ERC, ISF, GIF, etc.), her influence extends beyond research to shaping the global scientific agenda. She also received the Excellent Lecturer Award (2017) at Bar-Ilan University and serves as an academic reviewer and thesis evaluator for institutions across Israel, Europe, and Asia, demonstrating global academic leadership.

🔬 Research Focus

Dr. Frenkel-Morgenstern’s research centers on liquid biopsy technologies, cell-free nucleic acids (cfDNA/cfRNA), and systems and synthetic biology. Her lab investigates molecular biomarkers for cancer, arthritis, and prenatal diagnostics, developing computational platforms that utilize next-generation sequencing, AI, and machine learning. She explores chimeric RNAs, chromosomal translocations, and non-optimal codon usage, linking genetic regulation with disease mechanisms. Her interdisciplinary work bridges microbiome analysis, metagenomics, genome profiling, and protein-protein interaction networks, with translational applications in personalized medicine. In addition, she applies big data analytics to understand the cell cycle, identify druggable targets, and improve early diagnostics using non-invasive methods. Dr. Frenkel-Morgenstern is also investigating novel areas such as the relationship between melanin, Vitamin D, and mRNA technologies, relevant to both clinical and cosmetic science. Her research is both hypothesis-driven and data-intensive, aiming to convert large-scale biological data into practical medical insights and biotechnology solutions with significant societal impact.

✅ Conclusion

Dr. Milana Frenkel-Morgenstern is a leading scientist in bioinformatics and synthetic biology whose interdisciplinary research in liquid biopsies, systems biology, and AI-driven genomics continues to impact cancer diagnostics and translational medicine globally.

Publications

  • Applications for Circulating Cell-Free DNA in Oral Squamous Cell Carcinoma: A Non-Invasive Approach for Detecting Structural Variants, Fusions, and Oncoviruses

    Cancers
    2025-06 | Journal article | Author
    DOI: 10.3390/cancers17121901
    CONTRIBUTORS: Mahua Bhattacharya; Dan Yaniv; Dylan P. D’Souza; Eyal Yosefof; sharon tzelnick; Rajesh Detroja; Tal Wax; Adva Levy-Barda; Gideon Baum; Aviram Mizrachi et al.

  • ChiTaRS 8.0: the comprehensive database of chimeric transcripts and RNA-seq data with applications in liquid biopsy

    Nucleic Acids Research
    2025-01-06 | Journal article
    DOI: 10.1093/nar/gkae1126
    CONTRIBUTORS: Dylan DSouza; Lihi Bik; Olawumi Giwa; Shahaf Cohen; Hilit Levy Barazany; Tali Siegal; Milana Frenkel-Morgenstern

  • The applications of circulating cell-free DNA for oral squamous cell carcinoma patients as non-invasive diagnostics of structural variants, fusions and oncoviruses

    2023-11-30 | Preprint
    DOI: 10.1101/2023.11.29.23299177
    CONTRIBUTORS: Mahua Bhattacharya; Dan Yaniv; Eyal Yosefof; Sharon Tzelnick; Rajesh Detroja; Dylan P. D’Souza; Gidi Baum; Aviram Mizrachi; Gideon Bachar; Milana Frenkel Morgenster

Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Published on by Cognitive Scientist Awards

Dr. Ishrat Mahjabeen | Tumor Biomarkers | Best Scholar Award

Academician/Research Scholar |COMSATS University Islamabad, Pakistan

Dr. Ishrat Mahjabeen is an accomplished molecular biologist and cancer geneticist currently serving as Associate Professor at COMSATS University Islamabad, with extensive expertise in head and neck cancer, gene regulation, and microRNA biology. She earned her PhD in Cancer Genetics from COMSATS and recently completed a prestigious Fulbright Postdoctoral Fellowship at Brown University, USA. Dr. Mahjabeen has over two decades of research and academic experience, contributing significantly to molecular oncology through her work on base excision repair pathway genes, miRNA dysregulation, and genetic polymorphisms. She has also been an active educator, having supervised numerous undergraduate and graduate students and taught a variety of bioscience courses. Her scholarly contributions include a Springer book chapter and multiple international conference presentations. With a deep commitment to cancer research and academic mentorship, she continues to shape the future of biomedical science in Pakistan and beyond through her innovative work and international collaborations.

Profile

🎓 Education

Dr. Ishrat Mahjabeen holds a diverse academic background rooted in biological sciences. She earned her Postdoctoral Research Fellowship (2023–2024) from Brown University, USA, through the esteemed Fulbright Scholarship Program. Her PhD in Cancer Genetics was awarded by COMSATS Institute of Information Technology Islamabad in 2013, where she conducted a thesis on deregulated base excision repair pathway genes and microRNAs in head and neck cancer. Prior to her doctorate, she completed her M.Phil. in Developmental Biology from Quaid-e-Azam University in 2006, focusing on methylcobalamin’s role in sciatic nerve regeneration in rabbits. Her academic journey began with an MSc in Zoology from the University of Arid Agriculture Rawalpindi in 2003, where she explored the impact of temperature on arthropod populations. This strong foundation across developmental biology, zoology, and cancer genetics has equipped her with a multi-dimensional understanding of complex biological systems, enabling her significant contributions to cancer research and biosciences education.

🧪 Experience

Dr. Ishrat Mahjabeen has over 20 years of rich research and academic experience in biosciences and molecular oncology. Since May 2024, she has been serving as Associate Professor at COMSATS University Islamabad, where she previously held the positions of Assistant Professor (2017–2024) and Senior Scientific Officer (2014–2017). Her academic journey began with research fellowships at leading institutions, including the Center for Molecular Biology of Oral Diseases at the University of Illinois at Chicago, Quaid-e-Azam University, and PMAS Arid Agriculture University. She also contributed as an honorary lecturer in Talagang. As a committed educator, she has supervised over 140 students across BS, MS, and PhD levels and has taught advanced courses in molecular biology, research techniques, and biochemistry. Her leadership in academia is marked by dedication to translational cancer research, curriculum development, and capacity building in the life sciences, fostering innovation and scientific rigor among emerging researchers.

🏅 Awards and Honors

Dr. Ishrat Mahjabeen has been honored with the prestigious Fulbright Postdoctoral Research Fellowship (2023–2024) at Brown University, USA—an international recognition of her excellence in cancer genetics research. Her academic achievements and research impact have earned her continued faculty promotions within COMSATS University Islamabad, reflecting her contributions to teaching, student mentorship, and scientific leadership. She has received recognition for her work through invited talks and presentations at notable global scientific platforms, including the American Association of Extracellular Vesicles (AAEV 2023) in Boston and multiple international conferences in Turkey and Pakistan. Her chapter contribution in a Springer book on head and neck cancer highlights her thought leadership in molecular oncology. These accolades underscore her pioneering work in cancer biology, particularly in miRNA and gene regulation research, as well as her role in fostering academic excellence and collaborative innovation across borders.

🔬 Research Focus

Dr. Ishrat Mahjabeen’s research centers on molecular oncology with a focus on genetic and epigenetic mechanisms underlying cancer development, particularly head and neck cancers. Her PhD work explored deregulated base excision repair pathway genes and the role of microRNAs in tumor progression. She investigates how miRNA dysregulation, gene polymorphisms, and checkpoint kinase alterations contribute to tumorigenesis, with significant emphasis on gliomas, gastric cancer, and H. pylori-associated pathogenesis. Dr. Mahjabeen is also involved in studying exosomal miRNAs and their functional targets, aiming to identify biomarkers and therapeutic targets. Her translational research approach integrates molecular biology with bioinformatics to unravel cancer pathways and personalize treatment strategies. Her postdoctoral research at Brown University further broadened her scope, allowing global collaborations and access to advanced genomic tools. She remains committed to bridging basic research and clinical relevance to improve early cancer diagnostics and targeted therapies in low-resource healthcare settings.

✅ Conclusion

Dr. Ishrat Mahjabeen stands out as a dynamic academic and cancer researcher, combining excellence in teaching, mentorship, and cutting-edge molecular oncology. Her global exposure, leadership in translational research, and unwavering commitment to biosciences make her an asset to the scientific community.

4o
Publications

Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Ejaz Ahmad Khera | Materials Simulation | Best Researcher Award


Dr. Ejaz Ahmad Khera is an Assistant Professor of Physics at The Islamia University of Bahawalpur, Pakistan, and an HEC-approved supervisor with a PhD in the characterization of materials for memory storage and neuromorphic applications using DFT. He has published over 30 high-impact international research articles and currently leads research at the Materials Modeling and Simulation Lab, where he supervises MPhil and PhD students. His group is actively involved in developing efficient double perovskites for solar cell applications. In addition to his academic and research roles, Dr. Khera contributes to departmental administrative functions and has participated in multiple international conferences in physics and materials science. He is proficient in VASP, Wien2k, CASTEP, and other computational tools, reflecting his strong background in computational materials physics.

Profile

Education 🎓

Dr. Khera earned his PhD in Physics from The Islamia University of Bahawalpur (2016–2021), focusing on DFT-based characterization of materials for neuromorphic and memory applications. He holds an MPhil in Physics from Allama Iqbal Open University, Islamabad (2012–2014), and a Master of Science in Physics from Bahauddin Zakariya University, Multan (2007–2010). His academic foundation combines theoretical physics, computational modeling, and practical understanding of solid-state and condensed matter systems. He is trained in multiple simulation platforms including VASP, Wein2k, and CASTEP, and has built expertise in data analysis software like Origin and visualization tools like VESTA and Crystal Maker. His solid academic training has enabled him to mentor graduate students in computational material science and renewable energy research domains. Dr. Khera has also enhanced his academic exposure through participation in pedagogical and research methodology training programs.

Experience 👨‍🏫

Dr. Khera is currently serving as Assistant Professor of Physics at The Islamia University of Bahawalpur since March 2022, where he teaches undergraduate and postgraduate courses, leads research, and manages academic administration. From 2019 to 2021, he was a visiting lecturer at University of Education, Multan Campus, and previously taught physics at Admire Group of Colleges (2017–2021), Muslim Group of Colleges (2013–2017), and Educators Group of Colleges (2011–2013), focusing on undergraduate and higher secondary education. Over a decade of teaching experience has honed his expertise in delivering core physics concepts and mentoring students. In his academic tenure, Dr. Khera has also built research collaborations and guided MPhil and PhD students in materials modeling. His responsibilities have included curriculum design, academic planning, and seminar coordination. He is deeply engaged in academic development through active participation in physics conferences and workshops.

Awards & Recognitions 🏅

Dr. Khera received the Prime Minister Youth Laptop Scheme award from the Federal Government of Pakistan in 2018, recognizing his academic excellence and contribution to higher education. He was also granted the Punjab Government Scholarship under the Fee Reimbursement Scheme for Higher Education in 2017, awarded by the Government of Punjab. These honors reflect his academic merit, commitment to research, and service in the field of physics education. He has participated in multiple international and national-level conferences, including events hosted by The Islamia University of Bahawalpur and The Women University Multan. His consistent performance in academics and his role in teaching and research supervision have earned him institutional recognition. Additionally, his HEC-approved supervisor status further signifies his qualification and leadership in guiding advanced research projects in Pakistan. These accolades support his active involvement in national education development and scientific advancement in materials science.

Research Interests 🔬

Dr. Khera’s research is centered on computational materials science with a focus on density functional theory (DFT)-based investigations of electronic, optical, thermoelectric, and structural properties of novel materials. His primary interest lies in characterizing double perovskites (DPs), Heusler alloys, and vacancy-ordered compounds for use in solar cells, memory storage, brain-inspired neuromorphic systems, and energy harvesting applications. Using simulation tools like VASP, CASTEP, and Wien2k, he studies materials such as Ga₂PtX₆, Li₂ATlCl₆, and Na₂PtX₆ for their optoelectronic and thermoelectric performance. His recent publications explore halogen modification, spin polarization, and hybrid perovskites for sustainable technologies. His research group actively contributes to discovering lead-free, high-efficiency materials that align with global goals for clean and renewable energy. Dr. Khera also collaborates internationally, co-authoring papers with scientists across Asia and Europe, thereby advancing the field of computational physics and sustainable material development.

Publications

 

  • Probing the opto-electronic, thermoelectric, thermodynamic and elastic responses
    of lead-free double perovskite Li2ATlCl6 (A= Na and K) for potential photovoltaic
    and high-energy applications: A DFT study
    Reference: Qiguo Xiao, Abrar Nazir, Ejaz Ahmad Khera, Mumtaz Manzoor, Ramesh
    Sharma, Javed Rahman, Sabah Ansar, Farooq Ali
    Link: https://www.sciencedirect.com/science/article/pii/S0921510724006895

 

  • First principles investigation of structural, electronic, optical, transport properties
    of double perovskites X2TaTbO6 (X= Ca, Sr, Ba) for optoelectronic and energy
    harvesting applications
    Reference: Mudassir Ishfaq, Muniba Urooj, Muhammad Sajid, Khawar Ismail, Rimsha
    Baqeel, Ejaz Ahmad Khera, Rajwali Khan, Sattam Al Otaibi, Khaled Althubeiti, Hassan Ali,
    Ghulam Murtaza, Muhammad Jamil
    Link: https://www.sciencedirect.com/science/article/pii/S0022369724005675

 

 

Nathan Robert Wall | Medicine | Excellence in Research Award

Published on by Cognitive Scientist Awards

Dr. Nathan Robert Wall | Medicine | Excellence in Research Award

Dr. Nathan R. Wall is an accomplished academic, biomedical researcher, and military officer. He is currently an Associate Professor of Medicine at Loma Linda University School of Medicine and holds multiple leadership roles in research, oncology education, and national defense. With advanced degrees in biology, cancer biology, and business administration, he has dedicated his career to cancer research and military medical operations. Dr. Wall has served in multiple deployments with the California Army National Guard, including missions in Afghanistan, Poland, and Iraq. His military and academic excellence is recognized through numerous awards and honors. Dr. Wall combines rigorous research in molecular medicine with a passion for leadership, education, and national service. His extensive experience in academia, clinical research, and military command uniquely positions him at the intersection of science and strategic operations, contributing to both medical advancement and national security.

Profile

Education 🎓

Dr. Nathan R. Wall is currently pursuing a Master of Strategic Studies at the U.S. Army War College (2024–2026). He earned his MBA with a focus in Management from the University of Redlands (2006–2008), and a Ph.D. in Cancer Biology from Wayne State University (1996–2000), where he also completed an M.S. in Molecular Biology and Genetics. Prior to that, he obtained an M.S. in Biology (1992–1995) and a B.S. in Biology with a minor in Chemistry (1987–1991) from Walla Walla College (now Walla Walla University). His graduate training included mentorship under leading scientists like Dr. Ayad M. Al-Katib and Dr. Joan M. Redd. Across disciplines—from molecular biology to strategic leadership—Dr. Wall’s education reflects a commitment to interdisciplinary excellence, equipping him with the skills to navigate both biomedical research and complex military operations with strategic insight.

Experience 👨‍🏫

Dr. Nathan R. Wall has held academic appointments at Loma Linda University since 2008, currently serving as Associate Professor of Medicine in the Division of Human Anatomy. He also directs Research and Development at the James M. Slater Proton Treatment & Research Center and is Oncology Thread Director at the School of Medicine. Previously, he served in the Department of Biochemistry and Center for Health Disparities. Since 2008, Dr. Wall has simultaneously served in the California Army National Guard, rising through the ranks and completing deployments to Afghanistan, Poland, and Iraq in key command roles. He has also contributed as a scientific advisor for biotech firms and participated in Department of Defense medical research review panels. His interdisciplinary experience spans military medicine, molecular oncology, academic leadership, and national defense, making him a unique leader who bridges science, strategy, and service.

Awards & Recognitions 🏅

Dr. Wall’s exemplary service has earned him numerous military and civilian accolades. These include the Bronze Star Medal, NATO Medal, Afghanistan Campaign Medal, Global War on Terrorism Service Medal, and the Honorable Order of Saint Martin. He’s received multiple Army Commendation and Achievement Medals, along with California-specific honors like the California Medal of Merit and Drill Attendance Ribbon with multiple stars. Notably, he was recognized as “Citizen Warrior of the Month” by California ARNG Magazine in August 2018. Dr. Wall has also been honored with plaques and certificates from NATO, Bulgarian Joint Forces, and various military medical programs. His academic achievements include tenure at Loma Linda University and leadership roles in key training inspections. These honors reflect his unwavering commitment to excellence, leadership in medical readiness, and profound impact in both academic and military sectors.

Research Interests 🔬

Dr. Wall’s research focuses on cancer biology, with specific expertise in molecular mechanisms of disease, targeted therapies, and translational oncology. His work bridges basic science and clinical application, especially in the context of proton therapy and health disparities in underserved populations. At Loma Linda University, he leads interdisciplinary teams addressing tumor microenvironments, cancer signaling pathways, and innovative therapeutics. Dr. Wall also contributes to Department of Defense research as a peer reviewer, ensuring scientific rigor in funded medical studies. His research often integrates his military background, exploring how stress and trauma-related factors influence cancer biology and immune responses. As Director of R&D at a leading proton treatment center, he’s advancing precision medicine in oncology. Dr. Wall’s work is marked by its practical implications, scientific depth, and commitment to improving patient care—particularly for populations affected by health inequities or involved in military service.

Publications

  • Seco-Duocarmycin SA in Aggressive Glioblastoma Cell Lines

    International Journal of Molecular Sciences
    2025-03-19 | Journal article
    DOI: 10.3390/ijms26062766
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Ryan N. Fuller; Antonella Bertucci; Amy Nguyen; Quanqing Zhang; Tobias Emge; Kristopher E. Boyle; Nathan R. Wall; Marcelo Vazquez

  • A Comprehensive Review of the Antitumor Properties and Mechanistic Insights of Duocarmycin Analogs

    Cancers
    2024-09-27 | Journal article
    DOI: 10.3390/cancers16193293
    CONTRIBUTORS: Ann Morcos; Yeonkyu Jung; Joab Galvan Bustillos; Ryan N. Fuller; David Caba Molina; Antonella Bertucci; Kristopher E. Boyle; Marcelo E. Vazquez; Nathan R. Wal

  • A CTB-SARS-CoV-2-ACE-2 RBD Mucosal Vaccine Protects Against Coronavirus Infection

    Vaccines
    2023-12-18 | Journal article
    DOI: 10.3390/vaccines11121865
    CONTRIBUTORS: Béla Dénes; Ryan Fuller; Wayne Kelin; Tessa Levin; Jaipuneet Gil; Aaren Harewood; Márta Lőrincz; Nathan Wall; Anthony Firek; William Langridg

Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Jim Jinn-Chyuan Sheu | Precision medicine | Best Researcher Award

Dr. Jim Jinn-Chyuan Sheu is a professor at the Institute of Biomedical Sciences, National Sun Yat-sen University, Taiwan, and an adjunct professor in several prestigious institutions. With a PhD in Life Science from National Tsing-Hua University, his academic and industrial experiences span cancer genetics, precision medicine, and biopharmaceuticals. He has held positions at Johns Hopkins Medical Institutions and Development Center for Biotechnology. His research explores molecular mechanisms underlying diseases such as cancer and endometriosis, employing genome-wide technologies to identify biomarkers and drug targets. He actively contributes to biomedical innovation, translational medicine, and mentorship. Dr. Sheu has received numerous national and international awards, including the Wu-Da-You Memorial Award and Sigma Xi membership. He is also an ambassador for the European Association for Cancer Research. As a prolific researcher and reviewer, he plays key roles in research councils and institutional review boards, helping shape scientific policy and translational biomedical advancements in Taiwan and beyond.

Profile

Education 🎓

Dr. Sheu earned his Ph.D. in Life Science from National Tsing-Hua University, Taiwan, in 2002, where he focused on advanced molecular biology, gene expression regulation, and biomedical research. His doctoral training provided a strong foundation in cancer genetics and systems biology. Earlier, he completed his B.S. in Biology (now Life Science) from Fu-Jen University in 1994, building core competencies in biological sciences and cellular mechanisms. These educational milestones equipped him with theoretical knowledge and technical skills in genomics, proteomics, and cellular signaling, which are now reflected in his research on chromatin remodeling, cancer biomarkers, and therapeutic targets. Through rigorous academic mentorship, Dr. Sheu gained early exposure to multidisciplinary research and critical analysis, fostering his interest in precision medicine. His academic background laid the groundwork for his contributions to biomedical research, drug development, and translational science. These formative years in Taiwan’s top universities underpin his long-standing excellence in scientific discovery and innovation.

Experience 👨‍🏫

Dr. Sheu’s professional experience includes faculty roles and research leadership across academia and industry. He has served as a Professor at National Sun Yat-sen University since 2014 and previously held faculty roles at China Medical University. Internationally, he was a Research Fellow at Johns Hopkins Medical Institutions (2004–2006). Between 2003–2004, he worked in various leadership positions at the Development Center for Biotechnology, including Director of Protein Drugs Division and Project Leader. His postdoctoral and early research roles included work with Dr. Tse-Wen Chang and Dr. Carmay Lim at Academia Sinica. His academic leadership includes roles such as Associate VP of R&D, Chair of the Institute of Biomedical Sciences, and Director of Research Resources at NSYSU. He has reviewed research proposals for numerous hospitals and institutions, served on IRBs, and guided government research policy. His diverse experience bridges basic science, translational research, and biomedical entrepreneurship with national and global impact.

Awards & Recognitions 🏅

Dr. Sheu has received over 30 prestigious awards. In 2023 alone, he earned the Tien-Te Lee Award, NSYSU Outstanding Faculty Award, and top honors at the 37th Joint Biomedical Conference. He previously received the Prof. Chii-Ruey Tzeng Award, Sigma Xi membership (2021), and EACR Ambassador role (2020). His innovation was recognized by Future Tech Award and the 2020 Smart Life Innovation Competition. His studies were featured as Taiwan Research Highlights and F1000Prime recommendations. He was the 2014 recipient of the Wu-Da-You Memorial Award and the IBC Outstanding Scientific Achievement Award. He received the Medical Young Investigator Award in 2009 and the Best Basic Science Award at Johns Hopkins in 2005. As a government-financed scholar to the U.S., his academic excellence has been internationally recognized. He consistently ranks among Taiwan’s top biomedical researchers, illustrating his impact through award-winning research in endometriosis, cancer stemness, diagnostics, and therapeutic innovation.

Research Interests 🔬

Dr. Sheu’s research focuses on cancer genetics and genomics, endometriosis, precision medicine, chromatin remodeling, cytoskeletal dynamics, cell adhesion and invasion, and mechanotransduction. His lab investigates how abnormalities in gene expression and chromatin structure drive disease progression, especially in gynecologic cancers and endometriosis. By applying genome-wide analysis and bioinformatics, his team identifies disease-driving genes and develops novel diagnostic tools and therapeutic strategies. A key interest is the tumor microenvironment and how cytoskeletal networks and nuclear architecture influence cancer stemness and metastasis. His group explores traditional Chinese medicine compounds and stem cell therapies, advancing integrative approaches to medicine. Antibody and vaccine engineering are also integral to his translational pipeline. Funded by NSTC Taiwan and other institutions, his projects target non-invasive diagnostics and biomarker-based interventions. His long-term vision involves bridging molecular biology, clinical application, and therapeutic innovation to impact patient care and global health through interdisciplinary and precision-driven biomedical science.

Publications

Ali Osman | Life Science | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Ali Osman | Life Science | Best Researcher Award

👨‍🔬 Prof. Ali Osman Mohamed Osman Khalil is a distinguished biochemist specializing in agricultural sciences. 🎓 He earned his PhD in Biochemistry from Zagazig University, Egypt, in 2012. 🏫 Currently, he serves as a Professor at the Biochemistry Department, Faculty of Agriculture, Zagazig University. 📚 With over 130 international publications and an impressive h-index of 33 (Google Scholar), his research has significantly impacted agricultural biochemistry. 🏅 He has received prestigious awards, including the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and First Class Scientific Franchise from the President (2017). 🌱 His research focuses on environmentally friendly bioproducts, plant disease control, and biochemical applications in agriculture. 🌍 He is an active member of international scientific societies and serves as an external reviewer for renowned journals. ✨ Prof. Khalil has also collaborated on major scientific projects, contributing to advancements in biochemistry and sustainable agriculture.

Profile

Education 🎓

📜 Prof. Khalil holds a PhD in Biochemistry (2012) from Zagazig University, Egypt, with excellence. 🏆 His academic journey started with a B.Sc. in Agricultural Sciences-Biochemistry (2004), followed by an M.Sc. in Biochemistry (2008), both earned with distinction. 🎯 His studies focused on the biochemical mechanisms in agriculture, leading to his expertise in plant sterols, post-harvest protection, and biochemical applications in food science. 🔬 He has undertaken international fellowships, including INRA-France (2007-2008) and Umeå University-Sweden (2023-2024), enriching his research in clinical microbiology, infection, and immunology. 🌍 His educational background has provided a strong foundation for his pioneering research in agricultural biochemistry and food technology.

Experience 👨‍🏫

🔬 Prof. Khalil has over 20 years of academic experience at Zagazig University, Egypt. 📚 He began as a Teaching Assistant (2004-2008), then progressed to Assistant Lecturer (2008-2012) and Lecturer (2012-2017). 🎓 His expertise led to his promotion as an Assistant Professor (2017-2022) and later Professor (2022-present) in Biochemistry. 🏛️ His teaching covers biochemical applications in agriculture, plant metabolism, and molecular biochemistry. 🏅 He has supervised numerous postgraduate students, fostering the next generation of scientists. 🔍 As a principal investigator and collaborator in several international projects, he has worked on plant disease control, bioproduct development, and oxidation mechanisms. 📑 His editorial contributions include reviewing for top journals like LWT-Food Science and Technology, International Dairy Journal, and the African Journal of Agricultural Research. 🌍 His extensive research and teaching experience have solidified his reputation as a leading expert in biochemistry.

Awards & Recognitions 🏅

🎖️ Prof. Khalil has received numerous awards for his outstanding contributions to biochemistry and agricultural sciences. 🏅 In 2017, he was honored with the First Class Scientific Franchise by the Egyptian President for his scientific achievements. 🏆 He won the Egyptian State Prize for Encouragement in Agricultural Sciences (2014) and the Zagazig University Prize for Encouragement in Agricultural Sciences (2017). 🍏 His research excellence was recognized with the George Steno Award for Best Applied Research in Pomology (2017). 🌍 His global impact in plant biochemistry is further demonstrated by his international fellowships at INRA-France (2007-2008) and Umeå University-Sweden (2023-2024). 💡 As a member of esteemed scientific societies, including the American Chemical Society and Egyptian Botanical Society, he actively contributes to advancing agricultural research. 📚 His accolades reflect his dedication to innovation, sustainability, and scientific excellence in biochemistry

Research Interests 🔬

🌿 Prof. Khalil’s research primarily revolves around biochemical applications in agriculture, including post-harvest disease control, plant metabolism, and sustainable bioproducts. 🧪 His h-index of 33 (Google Scholar) and 132 SCOPUS-indexed publications highlight his impactful work. 🔍 As the Principal Investigator of projects like “Fighting Plant Fungi Post-Harvest Using Environmentally Friendly Bioproducts”, he explores innovative solutions for agricultural sustainability. 🌱 His research extends to plant sterol oxidation, polymerization, and antiviral strategies for plant protection. 📊 His expertise in biochemical pathways and molecular interactions has led to the development of novel biochemical strategies to enhance crop productivity and food safety. 🌍 His international collaborations, including a Spanish-Egyptian research project on molecular modeling, further advance his contributions to biochemistry, plant pathology, and environmental sustainability. ✨ His work bridges biochemistry and agriculture, making significant strides toward sustainable farming solutions

4Publications 

1. Eskandrani, A. A., Alsubaie, N., Bawahab, A. A., Abd-Elhakim, Y. M., Ibrahim, R. E.,
Khamis, T., Osman, A,… & Mohamed, A. A. R. (2025). Whey protein hydrolysate from
camel mitigates hypoxia-induced renal and gill damage in Nile Tilapia: Effects on stress, HIFα, apoptosis, inflammation, and metabolic pathways. Aquaculture, 742256.
2. Alsubaie, N., Mohamed, A. A. R., Metwally, M. M., Khamis, T., Osman, A., Alotaibi, B. S.,
… & Ibrahim, R. E. (2025). Alkalinity exposure induced growth inhibition, intestinal
histopathological changes, and down-regulated nutrient transporter expression in Nile Tilapia:
The ameliorative role of dietary camel whey protein hydrolysates. Comparative Biochemistry
and Physiology Part B: Biochemistry and Molecular Biology, 111074.
3. Alsubaie, N., Ibrahim, R. E., Bawahab, A. A., Mohamed, A. A. R., Abd-Elhakim, Y. M.,
Khamis, T., Osman, A., … & Ghannam, H. E. (2025). Ameliorative role of camel protein
hydrolysates diet against alkaline stress in Oreochrmis niloticus: Hematology, immune
responses and their regulating genes expression, and histopathological assays. Veterinary
Research Communications, 49(2), 79.
4. Dahran, N., Alotaibi, B. S., Abd-Elhakim, Y. M., Ibrahim, R. E., Metwally, M. M., Khamis,
T.,El-Far, A., Osman, A., … & Mohamed, A. A. R. (2025). Effects of camel whey protein
hydrolysate on growth, nutrient metabolism, and tight junction protein gene expression in
Oreochromis niloticus under hypoxia stress. Aquaculture International, 33(2), 137.
5. Elsheikh, M., Osman, A., Edris, S., Dawam, W., Sitohy, M., & Sabeq, I. (2024). Soybean
Glycinin’s Antibacterial Properties Provide a Feasible Natural Alternative for Improving the
Overall Quality and Shelf-Life of Beef Steaks and Combating Foodborne Pathogens. Food
and Bioprocess Technology, 1-16.
6. Amer, S. A., Ibrahim, R. E., Younis, E. M., Abdel-Warith, A. W. A., Osman, A., Davies, S.
J., & Shakweer, M. S. (2025). Potential of using kidney bean (Phaseolus vulgaris L) protein
hydrolysate as a plant protein supplement in Nile tilapia (Oreochromis niloticus) diets: effects
on growth, hematology, histology, and blood biochemical parameters. Aquaculture
International, 33(1), 95.
7. Amer, S. A., Behairy, A., Moustafa, A. A., Eltanahy, A., Younis, E. M., Abdel-Warith, A. W.
A., Osman, A., … & Tolba, S. A. (2024). Effects of dietary Arthrospira platensis phycocyanin
on growth, fatty acid assessment of breast muscles, hematobiochemical, immunological
responses, and hepatic histomorphology in broiler chickens. Journal of Applied
Phycology, 36(6), 3367-3380.
8. Ibrahim, R. E., Elshopakey, G. E., Aly, M. Y., Abdelwarith, A. A., Younis, E. M., AbdElhakim, Y. M., Khamis, T., Osman, A., … & Mohamed, A. A. R. (2024). Camel whey
protein hydrolysate diet mitigates alkaline stress–induced biochemical disorders and restores
the target of rapamycin, MAPK pathway, and autophagy-related gene expression in Nile
tilapia. Aquaculture International, 32(7), 9911-9932.
9. Sitohy, M., Enan, G., Abdel-Shafi, S., El-Wafa, N. A., El-Gazzar, N., Osman, A., & Sitohy,
B. (2024). Mapping pathogenic bacteria resistance against common antibiotics and their
potential susceptibility to methylated white kidney bean protein. BMC microbiology, 24(1),
49.
10. Amer, S. A., Rahman, A. N. A., ElHady, M., Osman, A., Younis, E. M., Abdel-Warith, A.
W. A., … & Ibrahim, R. E. (2024). Use of moringa protein hydrolysate as a fishmeal replacer
in diet of Oreochromis niloticus: effects on growth, digestive enzymes, protein transporters
and immune status. Aquaculture, 579, 740202.
11. Imbabi, T. A., El‐Sayed, A. I., Radwan, A. A., Osman, A., & Abdel‐Samad, A. M. (2024).
Prevention of aflatoxin B1 toxicity by pomegranate peel extract and its effects on growth,
blood biochemical changes, oxidative stress and histopathological alterations. Journal of
Animal Physiology and Animal Nutrition, 108(1), 174-184.

Engy Risha | Clinical Pathology | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. Engy Risha | Clinical Pathology | Best Researcher Award

Prof. Engy Fikry Mohamed Hassan Risha is the Vice Dean for Education and Student Affairs at Mansoura University – Faculty of Veterinary Medicine, Clinical Pathology. She has contributed 75 research publications in clinical pathology and veterinary sciences. With a strong academic background, she has held multiple administrative and academic positions, including Head of the Clinical Pathology Department (2015-2022). She has received numerous awards, including the Best PhD Thesis Award (2011) and International Publications Incentive Awards (2013-present). She actively participates in quality assurance, course standardization, and accreditation processes at her faculty. Additionally, she serves as a reviewer for several prestigious journals in veterinary and environmental sciences. Prof. Engy is proficient in clinical hematology, clinical chemistry, immunology, and molecular biology techniques. She has international research experience in Germany and expertise in statistical analysis, immunohistochemistry, and avian clinical pathology.

Profile

Education 🎓

📌 PhD in Clinical Pathology – Mansoura University, Egypt (2010)
📌 Master’s Degree in Clinical Pathology – Mansoura University, Egypt (2004)
📌 Bachelor of Veterinary Sciences (Honors) – Mansoura University, Egypt (2000)

Prof. Engy has progressively advanced through academic ranks, demonstrating excellence in veterinary clinical pathology. Her PhD research was part of a joint internal mission program between Hannover and Egypt (2008-2009), enhancing her expertise in molecular biology, histology, and immunological techniques. She has also undergone specialized training in avian clinical pathology, clinical hematology, chemistry, and immunology. Additionally, she holds an ICDL certification from UNESCO (2006), reflecting her strong computer skills for academic and research applications.

Experience 👨‍🏫

🔹 Vice Dean for Education and Student Affairs – Mansoura University (2022-2025)
🔹 Head of Clinical Pathology Department – Mansoura University (2015-2022)
🔹 Professor of Clinical Pathology – Mansoura University (2020-Present)
🔹 Assistant Professor of Clinical Pathology – Mansoura University (2015-2020)
🔹 Lecturer of Clinical Pathology – Mansoura University (2010-2015)
🔹 Assistant Lecturer – Mansoura University (2004-2010)
🔹 Demonstrator – Mansoura University (2001-2004)

She has significant expertise in immunohistochemistry, tissue culture, quantitative PCR, and virus infection assays from her research tenure at the University of Veterinary Medicine Hannover, Germany (2008-2009). She is also skilled in statistical analysis (t-test, ANOVA) and photographic histological documentation.

Research Interests 🔬

🔬 Clinical Pathology – Hematology, Chemistry, Immunology
🔬 Molecular Biology – Quantitative PCR, Virus Titration, Immunofluorescence
🔬 Histopathology & Immunohistochemistry – Antigen Retrieval Techniques, Tissue Culture
🔬 Avian Clinical Pathology – Veterinary Diagnostic Applications
🔬 Statistical Analysis – t-test, ANOVA, Data Interpretation

Prof. Engy has 75 research publications in high-impact journals, covering clinical and molecular pathology applications. She is an active reviewer for international journals such as Environmental Toxicology and Pharmacology, Applied Organometallic Chemistry, and the Polish Journal of Veterinary Sciences. She also plays a key role in strategic planning, curriculum development, and accreditation for veterinary education. 🚀

Awards & Recognitions 🏅

🏅 Best PhD Thesis Award – Mansoura University (2011)
🏅 International Publications Incentive Award – Mansoura University (2013-present)
🏅 PhD Joint Internal Mission Program – Hannover & Egypt (2008-2009)

Prof. Engy has been recognized for her outstanding contributions to veterinary medicine and research, particularly in clinical pathology. Her international research collaboration has significantly contributed to advancing veterinary diagnostic techniques.

Publications 

PhongSon Dinh | Gene function analysis | Best Researcher Award

Published on by Cognitive Scientist Awards

Dr. PhongSon Dinh | Gene function analysis | Best Researcher Award

Dr. Dinh Phong Son is a prominent researcher at Duy Tan University, Vietnam, specializing in laboratory medicine and molecular medicine. With a PhD from Guangxi Medical University, China, he is dedicated to advancing the field of molecular biology and medical diagnostics. His work focuses on identifying biomarkers for early disease detection and investigating gene targets for targeted therapies. He actively contributes to scientific advancements in understanding complex diseases such as cancer, diabetes, and cardiovascular diseases. Through his expertise in molecular techniques like CRISPR/Cas9, PCR, and sequencing, Dr. Son plays a vital role in improving medical diagnostics and treatments. 🧬🔬

Profile

Education 🎓

Dr. Dinh Phong Son holds a Doctorate (Ph.D.) in Molecular Medicine from Guangxi Medical University, China, after earning his degree in Laboratory Medicine from Hue University of Medicine and Pharmacy, Vietnam. His educational background has equipped him with the expertise in molecular biology, enabling him to explore complex diseases at a molecular level and work on cutting-edge technologies in the field of gene editing and disease diagnosis. 🎓📚

Experience 👨‍🏫

Dr. Dinh Phong Son has significant experience in molecular medicine, focusing on the development of biomarkers for early disease diagnosis and treatment. With expertise in molecular biology techniques such as PCR, qPCR, CRISPR/Cas9, and sequencing, he has conducted extensive research on diseases like cancer, cardiovascular disorders, and diabetes. His work integrates bioinformatics and molecular assays to understand gene functions and identify potential drug targets. He is actively contributing to scientific publications and advancing the research community’s knowledge in disease diagnostics and therapies. 🔬💡

Research Interests 🔬

Dr. Dinh Phong Son’s research focuses on molecular techniques for disease detection and gene therapy. His current work includes exploring circRNA, miRNA, mRNA, and their role in diseases like coronary heart disease and cancer. Dr. Son is particularly interested in developing diagnostic biomarkers and therapeutic targets for systemic diseases using next-generation sequencing and CRISPR/Cas9. He also investigates the interaction networks between lncRNA, circRNA, miRNA, genes, and proteins, aiming to create molecular-based solutions for precision medicine. His research paves the way for future advancements in molecular diagnostics and personalized therapies. 🔬🧬

Awards & Recognitions 🏅

Dr. Dinh Phong Son’s contributions to molecular medicine have earned him recognition in the scientific community. His research publications, particularly on gene networks and biomarkers in cardiovascular and cancer research, have garnered widespread attention. He is currently a nominee for the Best Researcher Award, reflecting his ongoing commitment to advancing the fields of molecular biology, gene therapy, and disease diagnostics. His work is an important step toward improving public health outcomes through the application of molecular techniques. 🏆🏅

Publications 📚

  • Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation

    Biochemistry and Biophysics Reports
    2025-03 | Journal article
    DOI: 10.1016/j.bbrep.2025.101952
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Hai-Anh Ha; Aigul Utegenova; Awais Ali; Abdulaziz Alamri

  • Hsa_circRNA_0000284 acts as a ceRNA to participate in coronary heart disease progression by sponging miRNA-338-3p via regulating the expression of ETS1

    Journal of Biomolecular Structure and Dynamics
    2024-07-02 | Journal article
    DOI: 10.1080/07391102.2023.2225109
    CONTRIBUTORS: PhongSon Dinh; ChauMyThanh Tran; ThiPhuongHoai Dinh; Awais Ali; ShangLing Pan

  • Potential diagnostic value of serum microRNAs for 19 cancer types: a meta-analysis of bioinformatics data

    Journal of Biomolecular Structure and Dynamics
    2024-03-15 | Journal article
    DOI: 10.1080/07391102.2024.2328744
    CONTRIBUTORS: ChauMyThanh Tran; PhongSon Dinh

  • Identification of hsa_circ_0001445 of a novel circRNA-miRNA-mRNA regulatory network as potential biomarker for coronary heart disease

    Frontiers in Cardiovascular Medicine
    2023-03-14 | Journal article
    DOI: 10.3389/fcvm.2023.1104223
    Part of ISSN: 2297-055X
    CONTRIBUTORS: PhongSon Dinh; JunHua Peng; ThanhLoan Tran; DongFeng Wu; ChauMyThanh Tran; ThiPhuongHoai Dinh; ShangLing Pan

Shilpa Kumari | Biotechnology | Best Researcher Award

Published on by Cognitive Scientist Awards

Ms.Shilpa Kumari | Biotechnology | Best Researcher Award

 

Sharda University, India

Profile

Education

She is currently pursuing a Ph.D. at Sharda University since 2020, having completed her coursework with an impressive 84.5%. She holds an M.Sc. in Biotechnology from Chandigarh University, where she secured 79.6% in 2019. Prior to that, she earned her B.Sc. from HNB Garhwal Central University, Srinagar, in 2017 with a score of 66.7%. She completed her 12th grade in the Medical stream under CBSE in 2014 with 74.4% and her 10th grade in General Science in 2012, securing 75.5%.

 

Awards

She has been awarded the Sharda University Research Scholarship (SURS) by Sharda University since February 2021. She received a Silver Medal at the 8th Annual Meeting of the International Association of Zoologists and the 5th International Conference on Recent Trends in Life Sciences and Biotechnology held at Maharishi Markandeshwar (Deemed to be University), Haryana, in December 2024. Additionally, she was granted International Travel Support from the Science and Engineering Research Board (SERB), Department of Science and Technology, Government of India, to present her research at the University Malay, Kuala Terengganu, Malaysia, in August 2024. She secured 2nd Prize at the Anveshan International Convention 2023-2024 (North Zone), organized by the Association of Indian Universities (AIU) in January 2024. Furthermore, she won the Best Oral Presentation Award at the National Conference on Disease Diagnosis and Drug Development Against Human Pathogens, sponsored by DBT and organized by Muthyammal College of Arts and Science in November 2023.

Book chapters

1. Shilpa Kumari, Neha Verma, Anil Kumar, Sunita Dalal, and Kanu Priya. “Functional
overrepresentation analysis and their application in microbial pathogenesis.” In Systems Biology
Approaches for Host-Pathogen Interaction Analysis, pp. 171-179. Academic Press, 2024.
2. Neha Verma, Shilpa Kumari, Anil Kumar, and Kanu Priya. “Advancements in systems biologybased analysis of microbial pathogenesis.” In Systems Biology Approaches for Host-Pathogen
Interaction Analysis, pp. 181-190. Academic Press, 2024

Publication